1. Home
  2. MHD vs ASMB Comparison

MHD vs ASMB Comparison

Compare MHD & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniHoldings Fund Inc.

MHD

Blackrock MuniHoldings Fund Inc.

HOLD

Current Price

$11.21

Market Cap

604.8M

Sector

Finance

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$36.46

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHD
ASMB
Founded
N/A
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
604.8M
512.1M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
MHD
ASMB
Price
$11.21
$36.46
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$44.20
AVG Volume (30 Days)
322.4K
278.2K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
4.16%
N/A
EPS Growth
N/A
91.78
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$638.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.05
$20.23
52 Week High
$12.08
$39.71

Technical Indicators

Market Signals
Indicator
MHD
ASMB
Relative Strength Index (RSI) 31.01 66.05
Support Level $11.16 $25.86
Resistance Level $11.99 $38.27
Average True Range (ATR) 0.11 1.83
MACD -0.02 0.14
Stochastic Oscillator 22.58 83.98

Price Performance

Historical Comparison
MHD
ASMB

About MHD Blackrock MuniHoldings Fund Inc.

Blackrock Muniholdings Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes. The fund mainly invests its managed assets in municipal bonds rated investment grade or, if unrated, are deemed to be of comparable quality by the investment adviser at the time of investment. Its investment portfolio is mainly comprised of long-term municipal bonds with a maturity of more than ten years at the time of investment. The fund can also invest directly in such securities or synthetically through the use of derivatives.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: